Erratum to: Reserpine Is the New Addition into the Repertoire of AcrB Efflux Pump Inhibitors [ Molecular Biology , 2019, Vol. 53, No. 4, pp. 596–605]

A. Shaheen; W. A. Afridi; S. Mahboob; M. Sana; N. Zeeshan; F. Ismat; O. Mirza; M. Iqbal; M. Rahman

doi:10.1134/S0026893319090012

Erratum to: Reserpine Is the New Addition into the Repertoire of AcrB Efflux Pump Inhibitors [Molecular Biology, 2019, Vol. 53, No. 4, pp. 596–605]

作者: Shaheen A.¹^,2, Afridi W.A.¹, Mahboob S.¹, Sana M.¹, Zeeshan N.², Ismat F.¹, Mirza O.³, Iqbal M.¹, Rahman M.¹
隶属关系:
1. Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE)
2. Department of Biochemistry and Biotechnology, University of Gujrat, Hafiz Hayat Campus
3. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen
期: 卷 53, 编号 5 (2019)
页面: 776-776
栏目: Erratum
URL: https://journals.rcsi.science/0026-8933/article/view/164085
DOI: https://doi.org/10.1134/S0026893319090012
ID: 164085

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
补充文件
统计

详细

erratum

作者简介

A. Shaheen

Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute
for Biotechnology and Genetic Engineering (NIBGE); Department of Biochemistry and Biotechnology, University of Gujrat, Hafiz Hayat Campus

Email: moazur.rahman@fulbrightmail.org
巴基斯坦, Faisalabad, 44000; Gujrat, 50700